Baxter (NYSE:BAX) shares closed up a tad today after the healthcare company reported 3rd-quarter results in line with its guidance and affirmed its sales outlook for the rest of the year.
MassDevice Earnings Roundup
Boston Scientific earnings: Writedown pushes BSX into Q3 red
Boston Scientific (NYSE:BSX) took a writedown for the 2nd consecutive quarter today, posting a 3rd-quarter loss and lowering its sales outlook for the rest of the year.
Still, excluding 1-time items, the Natick, Mass.-based medical device company managed to beat Wall Street’s expectations by a penny.
Stryker’s Q3 results dash Wall Street’s hopes
Stryker (NYSE:SYK) just missed Wall Street’s expectations with its 3rd-quarter earnings and reduced its forecast for 2012 and 2013 today, sending shares down a tad in after-hours trading.
The Kalamazoo, Mich.-based medical device company cited "weaker results from key countries outside the U.S." and softer sales for its capital equipment business.
Abbott narrows 2012 guidance, announces more layoffs and tempers M&A outlook
St. Jude Medical slides on potential FDA warning, lowered outlook
St. Jude Medical‘s (NYSE:STJ) stock took a hit today after the medical device company said it might get a warning from the FDA over one of its California factories and lowered its outlook for the rest of the year.
Intuitive Surgical slides after hours on lower procedure volumes
Intuitive Surgical (NSDQ:ISRG) delivered another Street-beating quarter today, but investors, spooked by sliding procedure volumes, shaved more than 5% from its share price in after-hours trading.
Johnson & Johnson hits 52-week high on boosted earnings forecast | Wall Street Beat
Shares of Johnson & Johnson (NYSE:JNJ) surged to a 52-week high today after the healthcare conglomerate boosted its 2012 earnings forecast after reporting a solid, Street-beating quarter (and despite a nearly 18% bottom-line slide).
FLASH: Johnson & Johnson reports Q3 earnings slip 18%, boosts outlook
Johnson & Johnson (NYSE:JNJ) beat Wall Street’s earnings expectations and boosted its profit outlook for the rest of the year this morning before the market’s open.
The New Brunswick, N.J.-based healthcare giant posted profits of $2.63 billion, or $1.05 per diluted share, on sales of $17.05 billion during the 3 months ended Sept. 30.
AngioDynamics slides hard on Street-beating quarter, earnings-lowering acquisition
AngioDynamics (NSDQ:ANGO) shares took a dive as the company released its 1st quarter earnings report, announced an acquisition worth at least $55 million over the next 5 years and disclosed a shareholder class action lawsuit filed late last month.
Misonix gains 19% on swing to black | Wall Street Beat
Misonix (NSDQ:MSON) shares are up 19% today after the medical device company swung to black ink for its fiscal 4th quarter and full year.
Farmingdale, N.Y.-based Misonix posted profits of $366,000, or 5¢ per share, on sales of $1.7 million for the 12 months ended June 30 – for a 26.7% top-line gain that helped Misonix swing from a $3.5 million loss during its last fiscal year.